FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Most people hear not FDA approved and immediately think unsafe or ineffective but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to BPC 157 and Female Fertility: Effects, Mechanisms, Safety and Risks The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York